Voleon Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.79M Sell
24,186
-67,740
-74% -$7.29M 0.05% 300
2026
Q2
$7.99M Sell
91,926
-170,297
-65% -$10.3M 0.15% 143
2026
Q1
$10.6M Buy
+262,223
New +$9.8M 0.23% 101
2025
Q4
– Sell
-2,815
Closed -$234K – 832
2025
Q3
$234K Buy
+2,815
New +$204K 0.01% 790

Other funds holding CORT

Voleon Capital Management's CORT Position: Q3 2026 in Review

Voleon Capital Management reduced its Corcept Therapeutics (CORT) stake by 74% in Q3 2026, selling an estimated $7.29M and leaving 24,186 shares worth $2.79M. The position accounts for 0.05% of the portfolio, ranked #300.

Voleon Capital Management first reported a position in CORT in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.6M in Q1 2026. 500 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Voleon Capital Management held 24,186 shares of Corcept Therapeutics worth $2.79M as of Q3 2026.
  • Voleon Capital Management sold 67,740 Corcept Therapeutics shares in Q3 2026, an estimated $7.29M.
  • Corcept Therapeutics made up 0.05% of Voleon Capital Management's portfolio in Q3 2026, its #300 holding.
  • Voleon Capital Management first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Voleon Capital Management's Corcept Therapeutics position peaked at $10.6M in Q1 2026.
  • 500 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.